| P50 | author | Antonio Maria Morselli-Labate | Q67905598 |
| P2093 | author name string | Roberto Corinaldesi | |
| | Raffaele Pezzilli | |
| P2860 | cites work | Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis | Q24655364 |
| | Pattern of NSAID use in the Italian general population: a questionnaire-based survey | Q28171365 |
| | A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment | Q28175168 |
| | Salycylate--induced pancreatic injury in the cat: a preliminary study | Q28194659 |
| | Adverse drug reactions leading to hospital admission | Q28325574 |
| | Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats | Q28344833 |
| | The protecting effects and mechanisms of Baicalin and Octreotide on heart injury in rats with SAP | Q28577045 |
| | Therapy of patients with chronic pancreatitis of alcoholic etiology by dalagrin and laser therapy of the blood | Q30981724 |
| | Resveratrol ameliorates hepatic injury via the mitochondrial pathway in rats with severe acute pancreatitis | Q33381953 |
| | Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. | Q33408074 |
| | [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine] | Q74299368 |
| | Serum lipase, C-reactive protein, and interleukin-6 levels in ERCP-induced pancreatitis | Q74568916 |
| | [Benign acute pancreatitis probably due to taking ketoprofen] | Q74591457 |
| | Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography | Q75427953 |
| | [Dimephosphon in complex therapy of acute edematous pancreatitis] | Q76401714 |
| | Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis | Q77180981 |
| | Role of enteral nutrition supplemented with ebselen and EHEC in pancreatitis-associated multiple organ dysfunction in rats | Q79363949 |
| | [Prevention of hyperamilasemia and pancreatitis after endoscopic retrograde cholangiopancreatography with rectal administration of indomethacin] | Q79398514 |
| | Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis | Q79674681 |
| | Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP | Q79929503 |
| | Inhibition of cyclooxygenase-2 in experimental severe acute pancreatitis | Q80149335 |
| | Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail | Q80297627 |
| | Effects of dual inhibitor of cyclooxygenase and 5-lipoxygenase on acute necrotizing pancreatitis in rats | Q80330922 |
| | Indomethacin-induced pancreatitis: a case report | Q80352226 |
| | Protective effects of baicalin and octreotide on multiple organ injury in severe acute pancreatitis | Q80430450 |
| | Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial | Q80537945 |
| | Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography | Q81769288 |
| | In vitro and in vivo nuclear factor-kappaB inhibitory effects of the cell-penetrating penetratin peptide | Q82675855 |
| | Indomethacin-induced pancreatitis. A second case report | Q83310780 |
| | [Piroxicam and acute pancreatitis] | Q83868870 |
| | Safety and efficacy of conservative management in acute severe pancreatitis | Q83922974 |
| | Cyclooxygenase-2 plays a central role in the genesis of pancreatitis and associated lung injury. | Q45282550 |
| | Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis | Q46071471 |
| | Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury | Q46112345 |
| | Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition | Q46223466 |
| | Influence of baicalin and octreotide on NF-kappaB and p-selectin expression in liver and kidney of rats with severe acute pancreatitis | Q46230552 |
| | Flurbiprofen and HCT1026 protect mice against acute pancreatitis-associated lung injury | Q46619019 |
| | Effects of the celecoxib on the acute necrotizing pancreatitis in rats | Q46679853 |
| | Protection effect of triptolide to liver injury in rats with severe acute pancreatitis. | Q46802528 |
| | The effect of CP96,345 on the expression of tachykinins and neurokinin receptors in acute pancreatitis | Q46862571 |
| | Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial | Q46864355 |
| | Effects of resveratrol on calcium regulation in rats with severe acute pancreatitis | Q46887169 |
| | Acute pancreatitis after treatment by celecoxib | Q46958821 |
| | Influence of nitric oxide-donating nonsteroidal anti-inflammatory drugs on the evolution of acute pancreatitis | Q46981585 |
| | Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis | Q46981742 |
| | Zerumbone exerts a beneficial effect on inflammatory parameters of cholecystokinin octapeptide-induced experimental pancreatitis but fails to improve histology. | Q46981745 |
| | Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes | Q46990580 |
| | The use of drotrecogin alfa (activated) in severe sepsis during acute pancreatitis - two case studies. | Q47251966 |
| | Is indomethacin a new hope for post-ERCP pancreatitis? | Q47572760 |
| | Use of dalargin in the treatment of acute cholecystopancreatitis complicated by obstructive jaundice | Q50162870 |
| | Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study. | Q33493634 |
| | Acute pancreatitis secondary to 5-aminosalicylic acid therapy in a patient with ulcerative colitis | Q33715613 |
| | Effect of resveratrol on microcirculation disorder and lung injury following severe acute pancreatitis in rats | Q34382381 |
| | Pancytopenia, hyperglycemia, shock, coma, rhabdomyolysis, and pancreatitis associated with acetaminophen poisoning | Q34471277 |
| | Mechanisms involved in the onset of post-ERCP pancreatitis. | Q34997294 |
| | Adjusting effects of baicalin for nuclear factor-kappaB and tumor necrosis factor-alpha on rats with caerulein-induced acute pancreatitis | Q35161474 |
| | A selective COX-2 inhibitor suppresses chronic pancreatitis in an animal model (WBN/Kob rats): significant reduction of macrophage infiltration and fibrosis | Q35760595 |
| | Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis | Q35871223 |
| | Neurogenic inflammation and pancreatitis | Q35954121 |
| | Resveratrol: a medical drug for acute pancreatitis | Q36147106 |
| | Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis | Q36576621 |
| | A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis | Q37122770 |
| | Pharmacotherapy for acute pancreatitis | Q37635105 |
| | Decreased inflammation and improved survival with recombinant human activated protein C treatment in experimental acute pancreatitis | Q38583952 |
| | Acute phase response in patients with uncomplicated and complicated endoscopic retrogradic cholangiopancreaticography | Q39035770 |
| | Efficacy and tolerance of metamizole versus morphine for acute pancreatitis pain | Q39324418 |
| | Procaine hydrochloride fails to relieve pain in patients with acute pancreatitis | Q39384729 |
| | Buprenorphine or procaine for pain relief in acute pancreatitis. A prospective randomized study | Q39422099 |
| | Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis? | Q40386858 |
| | A case of acute pancreatitis caused by 5-aminosalicylic acid suppositories in a patient with ulcerative colitis | Q40431157 |
| | Cytokine production by CAPAN-1 and CAPAN-2 cell lines | Q40882342 |
| | The mechanisms of action of NSAIDs in analgesia | Q41217565 |
| | Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls | Q41603966 |
| | Selective cyclooxygenase-2 inhibitor ameliorates cholecystokinin-octapeptide-induced acute pancreatitis in rats | Q41840456 |
| | Regressive fulminant hepatitis, acute pancreatitis and renal insufficiency after taking ketoprofen | Q42536955 |
| | Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. | Q43462303 |
| | Acute pancreatitis and ketoprofen | Q43775250 |
| | Acute pancreatitis caused by ketorolac tromethamine | Q43901931 |
| | Transdermal fentanyl for the management of acute pancreatitis pain | Q43982762 |
| | Acute pancreatitis associated with rofecoxib | Q43988187 |
| | A Swedish case-control network for studies of drug-induced morbidity--acute pancreatitis | Q44075852 |
| | Curcumin ameliorates ethanol and nonethanol experimental pancreatitis | Q44253287 |
| | Acute pancreatitis: a rare complication of celecoxib | Q44269588 |
| | Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography | Q44477955 |
| | Prevention of post-ERCP pancreatitis: pharmacologic solution or patient selection and pancreatic stents? | Q44477974 |
| | Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination? | Q44492424 |
| | Selective inhibition of cyclooxygenase-2 (COX-2) reduces prostaglandin E2 production and attenuates systemic disease sequelae in experimental pancreatitis. | Q44503317 |
| | Acute pancreatitis after long-term therapy with mesalazine, and hyperamylasaemia associated with azathioprine in a patient with ulcerative colitis | Q44516455 |
| | Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis | Q44579635 |
| | Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil | Q44713629 |
| | Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis | Q44748246 |
| | COX-2 inhibition results in alterations in nuclear factor (NF)-kappaB activation but not cytokine production in acute pancreatitis | Q44878284 |
| | Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis | Q44969138 |
| | Lanreotide autogel is a therapeutic option for patients who develop acute pancreatitis after somatostatin analog treatment | Q45271026 |
| | Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. | Q51538013 |
| | Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk. | Q51824139 |
| | A prospective multicentre survey on the treatment of acute pancreatitis in Italy. | Q51911459 |
| | Acute pancreatitis following naproxen intake. | Q53513273 |
| | Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis | Q57300657 |
| | Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis | Q58441012 |
| | Indomethacin treatment of acute pancreatitis. A controlled double-blind trial | Q68943884 |
| | Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain | Q70543652 |
| | Possible association of acute pancreatitis with naproxen | Q71120412 |
| | [A case of pancreatic pleural effusion and ascites treated successfully with conservative measures including octreotide and nafamostat mesilate] | Q71951569 |
| | Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease | Q72592613 |
| | Antipyrine, oxazepam, and indocyanine green clearance in patients with chronic pancreatitis and healthy subjects | Q73025208 |
| | Expression of pancreatitis-associated protein (PAP) in rat spontaneous chronic pancreatitis: effect of herbal medicine Saiko-keishi-to (TJ-10) | Q73040025 |
| | [Acute pancreatitis--adverse effect of 5-aminosalicylic acid (mesalazine) in various galenic dosage forms] | Q73277458 |
| | Antifibrotic effect of the herbal medicine Saiko-keishi-to (TJ-10) on chronic pancreatitis in the WBN/Kob rat | Q73347215 |
| | Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography | Q73400320 |
| | Celecoxib-induced acute pancreatitis and hepatitis: a case report | Q73495274 |
| | Acute pancreatitis associated with celecoxib | Q73680310 |
| | Acute pancreatitis after long-term 5-aminosalicylic acid therapy | Q73943261 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | acute pancreatitis | Q854573 |
| | systematic review | Q1504425 |
| P304 | page(s) | 558-571 | |
| P577 | publication date | 2010-03-10 | |
| P1433 | published in | Pharmaceuticals | Q15750667 |
| P1476 | title | NSAIDs and Acute Pancreatitis: A Systematic Review | |
| P478 | volume | 3 | |